Arecor's Partner Inhibrx Exercises Its Option to License a New Formulation Developed by Arecor in Accordance With the Terms of ...
CAMBRIDGE, United Kingdom, Dec. 17, 2020 (GLOBE NEWSWIRE) -- Arecor Ltd ("Arecor" or "the Company"), the biopharmaceutical company advancing today's therapies to enable healthier lives, today announces that its partner, Inhibrx, Inc …